A Time-Saving Medical Device that Provides Automated Visualisation for interventional radiologists to Save Lives and Reduce Disabilities in Stroke Patient

一种节省时间的医疗设备，可为介入放射科医生提供自动可视化，以挽救中风患者的生命并减少残疾

• 批准号: 10023447
• 金额: $ 41.84万
• 依托单位: MEDICAL ISIGHT (UK) LTD.
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10023447
• 关键词: Time; Saving; Medical; Device; Provides

Strokes in the UK incur annual costs of £26B and in the US $103B. Medical iSight (UK) Limited (MiS) is solving a significant, unmet, global need that could save lives and reduce disability for tens of thousands of UK patients each year, while generating a year-5 post- project revenue of £36M. The core project team from MiS includes Dr Christopher Johnson, Dr Philip Pratt, Dr Robert Merrifield and Ms Anna Schaffgotsch, a technology programme director, a medical software engineer, a medtech software CTO and a serial entrepreneur.MiS aims to simplify Mechanical Thrombectomy (MT), a relatively new and highly effective treatment for large vessel occlusive ischaemic Stroke. MT is a highly skilled and challenging procedure with some lasting 4-5 hours.In its Long Term Plan the NHS identified Stroke as a clinical priority and aims to make MT accessible to every suitable Stroke patient throughout the UK, developing up to 30 Stroke centres capable of delivering MT, nationally.Unlike the technology used by many competitors, this project aims to provide automated 3D to 2D image registration and catheter tip tracking within an extended reality environment (Microsoft HoloLens), making the procedure simpler and shorter (c30%), using established metrics to measure success.

中风在英国每年花费260亿英镑，在美国花费1030亿美元。医疗iSight（英国）有限公司（MiS）正在解决一个重大的、未得到满足的全球需求，每年可以为数万名英国患者挽救生命和减少残疾，同时产生3. 6亿英镑的项目后5年收入。MiS的核心项目团队包括Christopher约翰逊博士、Philip Pratt博士、Robert梅里菲尔德博士和安娜·沙夫戈奇女士，他们分别是技术项目总监、医疗软件工程师、医疗技术软件首席技术官和连续创业者。MiS旨在简化机械血栓切除术（MT），这是一种相对较新且高效的治疗大血管闭塞性缺血性卒中的方法。MT是一种高度熟练和具有挑战性的程序，有些持续4-5小时。在其长期计划中，NHS将中风确定为临床优先事项，旨在使MT可用于英国各地的每一位合适的中风患者，在全国范围内开发多达30个能够提供MT的中风中心。与许多竞争对手使用的技术不同，该项目旨在在延展实境环境（Microsoft HoloLens）中提供自动3D到2D图像配准和导管头端跟踪，使手术更简单、更短（c30%），使用已建立的指标来衡量成功。